Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Galera Therapeutics doses first patient in Phase III trial of GC4419

Severe oral mucositis is the most devastating side effect of radiotherapy. Credit: Nic McPhee.



  • Radiotherapy

Go Top